Show simple item record

dc.contributor.authorLittleton, J. Troy
dc.contributor.authorZhang, Sheng
dc.contributor.authorSaraswati, Sudipta
dc.contributor.authorFeany, Mel B.
dc.contributor.authorPerrimon, Norbert
dc.date.accessioned2010-07-14T14:51:01Z
dc.date.available2010-07-14T14:51:01Z
dc.date.issued2009-05
dc.date.submitted2008-04
dc.identifier.issn1754-8403
dc.identifier.issn1754-8411
dc.identifier.urihttp://hdl.handle.net/1721.1/56290
dc.description.abstractA polyglutamine expansion in the huntingtin (HTT) gene causes neurodegeneration in Huntington’s disease (HD), but the in vivo function of the native protein (Htt) is largely unknown. Numerous biochemical and in vitro studies have suggested a role for Htt in neuronal development, synaptic function and axonal trafficking. To test these models, we generated a null mutant in the putative Drosophila HTT homolog (htt, hereafter referred to asdhtt) and, surprisingly, found that dhtt mutant animals are viable with no obvious developmental defects. Instead, dhtt is required for maintaining the mobility and long-term survival of adult animals, and for modulating axonal terminal complexity in the adult brain. Furthermore, removing endogenous dhtt significantly accelerates the neurodegenerative phenotype associated with a Drosophila model of polyglutamine Htt toxicity (HD-Q93), providing in vivo evidence that disrupting the normal function of Htt might contribute to HD pathogenesis.en_US
dc.language.isoen_US
dc.publisherCompany of Biologistsen_US
dc.relation.isversionofhttp://dx.doi.org/10.1242/dmm.000653en_US
dc.rightsAttribution-Noncommercial-Share Alike 3.0 Unporteden_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/en_US
dc.sourceJ. Troy Littletonen_US
dc.titleInactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington’s disease modelen_US
dc.typeArticleen_US
dc.identifier.citationZhang, Sheng et al. “Inactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington’s disease model.” Disease Models & Mechanisms 2.5-6 (2009): 247-266.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.approverLittleton, J. Troy
dc.contributor.mitauthorLittleton, J. Troy
dc.contributor.mitauthorSaraswati, Sudipta
dc.relation.journalDisease Models and Mechanismsen_US
dc.eprint.versionAuthor's final manuscript
dc.type.urihttp://purl.org/eprint/type/Reporten_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsZhang, S.; Feany, M. B.; Saraswati, S.; Littleton, J. T.; Perrimon, N.en
dc.identifier.orcidhttps://orcid.org/0000-0001-5576-2887
mit.licenseOPEN_ACCESS_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record